GreenLight Biosciences Holdings NASDAQ:GRNA

Financial Health
0
1
2
3
4
5
6
7
8
9

GreenLight Biosciences Holdings stock price monthly change

+48.24%
month

GreenLight Biosciences Holdings stock price quarterly change

-31.71%
quarter

GreenLight Biosciences Holdings stock price yearly change

-93.33%
year

GreenLight Biosciences Holdings key metrics

Market Cap
45.42M
Enterprise value
74.41M
P/E
-0.42
EV/Sales
8.70
EV/EBITDA
N/A
Price/Sales
7.25
Price/Book
1.29
PEG ratio
N/A
EPS
-1.17
Revenue
10.20M
EBITDA
-146.68M
Income
-158.07M
Revenue Q/Q
1386.38%
Revenue Y/Y
3870.42%
Profit margin
-176177690.47%
Oper. margin
-1803.12%
Gross margin
20.68%
EBIT margin
-1803.12%
EBITDA margin
-1437.56%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

GreenLight Biosciences Holdings stock price history

GreenLight Biosciences Holdings stock forecast

GreenLight Biosciences Holdings financial statements

GreenLight Biosciences Holdings (NASDAQ:GRNA): Profit margin
Jun 2022 1.74M -51.89M -2968.65%
Sep 2022 1.68M -38.15M -2259.21%
Dec 2022 2.94M -39.97M -1356.6%
Mar 2023 3.82M -28.04M -734.11%
GreenLight Biosciences Holdings (NASDAQ:GRNA): Debt to assets
Jun 2022 98810000 85.08M 86.11%
Sep 2022 151418000 67.00M 44.25%
Dec 2022 148598000 100.53M 67.66%
Mar 2023 113689000 91.75M 80.71%
GreenLight Biosciences Holdings (NASDAQ:GRNA): Cash Flow
Jun 2022 -22.69M -12.58M -3.81M
Sep 2022 -39.97M -10.07M 104.27M
Dec 2022 -24.58M -3.60M -2.06M
Mar 2023 -31.06M -1.60M -2.98M

GreenLight Biosciences Holdings alternative data

GreenLight Biosciences Holdings (NASDAQ:GRNA): Employee count
Aug 2023 280
Sep 2023 280
Oct 2023 280
Nov 2023 280
Dec 2023 280
Jan 2024 280
Feb 2024 280
Mar 2024 280
Apr 2024 280
May 2024 280
Jun 2024 280
Jul 2024 280

GreenLight Biosciences Holdings other data

12.90% -14.17%
of GRNA is owned by hedge funds
17.02M -20.61M
shares is hold by hedge funds

GreenLight Biosciences Holdings (NASDAQ:GRNA): Insider trades (number of shares)
Period Buy Sel
Aug 2022 9502550 0
Jul 2023 0 9188659
Transaction Date Insider Security Shares Price per share Total value Source
Sale
CORMORANT ASSET MANAGEMENT, LP
Common Stock 9,188,659 N/A N/A
Purchase
MORNINGSIDE VENTURE INVESTMENTS LTD director:
Common Stock 3,061,224 $3.92 $11,999,998
Purchase
BUILDERS VISION, LLC director:
Common Stock 6,377,551 $3.92 $25,000,000
Purchase
WALKER MATTHEW ALLEN director:
Common Stock 63,775 $3.92 $249,998
Option
ORTEGA-VALLE MARTA officer: Chief Business Officer
Stock Option (Right to Buy) 29,798 N/A N/A
Purchase
MORNINGSIDE VENTURE INVESTMENTS LTD 10 percent owner
Common Stock 1,000,000 N/A N/A
Purchase
WALKER MATTHEW ALAN director, 10 percent owner:
Common Stock 1,500,000 $10 $15,000,000
Purchase
KISHORE GANESH director
Common Stock 75,000 $10 $750,000
Purchase
OBRIEN ERIC director, 10 percent owner:
Common Stock 700,000 $10 $7,000,000
Purchase
MORNINGSIDE VENTURE INVESTMENTS LTD 10 percent owner
Common Stock 1,000,000 N/A N/A
  • When is GreenLight Biosciences Holdings's next earnings date?

    Unfortunately, GreenLight Biosciences Holdings's (GRNA) next earnings date is currently unknown.

  • Does GreenLight Biosciences Holdings pay dividends?

    No, GreenLight Biosciences Holdings does not pay dividends.

  • How much money does GreenLight Biosciences Holdings make?

    GreenLight Biosciences Holdings has a market capitalization of 45.42M.

  • What is GreenLight Biosciences Holdings's stock symbol?

    GreenLight Biosciences Holdings is traded on the NASDAQ under the ticker symbol "GRNA".

  • What is GreenLight Biosciences Holdings's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of GreenLight Biosciences Holdings?

    Shares of GreenLight Biosciences Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does GreenLight Biosciences Holdings have?

    As Jul 2024, GreenLight Biosciences Holdings employs 280 workers.

  • When GreenLight Biosciences Holdings went public?

    GreenLight Biosciences Holdings is publicly traded company for more then 3 years since IPO on 3 Feb 2022.

  • What is GreenLight Biosciences Holdings's official website?

    The official website for GreenLight Biosciences Holdings is greenlightbiosciences.com.

  • Where are GreenLight Biosciences Holdings's headquarters?

    GreenLight Biosciences Holdings is headquartered at 200 Boston Avenue, Medford, MA.

  • How can i contact GreenLight Biosciences Holdings?

    GreenLight Biosciences Holdings's mailing address is 200 Boston Avenue, Medford, MA and company can be reached via phone at +61 76168188.

GreenLight Biosciences Holdings company profile:

GreenLight Biosciences Holdings

greenlightbiosciences.com
Exchange:

NASDAQ

Full time employees:

280

Industry:

Biotechnology

Sector:

Healthcare

GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts.

200 Boston Avenue
Medford, MA 02155

CIK: 0001822691
ISIN: US39536G1058
CUSIP: 39536G105